ZSCAN2: A Potential Drug Target for Cancer (G54993)

Target Name: ZSCAN2

NCBI ID: G54993

ZSCAN2

ZSCAN2: A Potential Drug Target for Cancer

ZSCAN2 (ZSCA2_HUMAN), a protein that is expressed in various tissues of the human body, including the brain, has been identified as a potential drug target or biomarker. The ZSCAN2 gene has been shown to play a role in a number of physiological processes, including cell adhesion, migration, and survival.

One of the key functions of ZSCAN2 is its role in cell adhesion. This protein is known to be involved in the process of tight junction formation, which is critical for the proper functioning of tissues that are barrier-bound. ZSCAN2 has been shown to be involved in the formation of tight junctions between epithelial cells, which are responsible for maintaining the integrity of the skin and other barrier tissues.

Another function of ZSCAN2 is its role in cell migration. This protein has been shown to be involved in the migration of various types of cells, including cancer cells. ZSCAN2 has been shown to promote the migration of cancer cells through the bloodstream, which could potentially contribute to the development and progression of cancer.

In addition to its role in cell adhesion and migration, ZSCAN2 has also been shown to play a role in cell survival. This protein has been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die when they have reached a certain level of stress or damage. ZSCAN2 has been shown to protect cells from apoptosis, which could potentially lead to the development of cancer.

The potential drug target or biomarker that ZSCAN2 represents is its involvement in cell adhesion, migration, and survival. These processes are critical for the development and progression of cancer, and targeting ZSCAN2 could potentially lead to the development of new treatments for this disease.

In conclusion, ZSCAN2 is a protein that has been shown to play a number of important roles in various physiological processes in the human body. Its potential as a drug target or biomarker makes it an attractive target for research into the development of new treatments for cancer. Further studies are needed to fully understand the role of ZSCAN2 in these processes and to develop effective treatments.

Protein Name: Zinc Finger And SCAN Domain Containing 2

Functions: May be involved in transcriptional regulation during the post-meiotic stages of spermatogenesis

The "ZSCAN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSCAN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets